Ryan Fukushima Sells 20,000 Shares of Tempus AI (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM) CEO Ryan Fukushima sold 20,000 shares of the business’s stock in a transaction on Friday, August 7th. The shares were sold at an average price of $50.04, for a total transaction of $1,000,800.00. Following the sale, the chief executive officer directly owned 123,945 shares in the company, valued at approximately $6,202,207.80. This trade represents a 13.89% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Ryan Fukushima also recently made the following trade(s):

• On Monday, August 3rd, Ryan Fukushima sold 23,818 shares of Tempus AI stock. The stock was sold at an average price of $46.19, for a total value of $1,100,153.42.
• On Wednesday, July 8th, Ryan Fukushima sold 33,284 shares of Tempus AI stock. The shares were sold at an average price of $57.39, for a total value of $1,910,168.76.
• On Monday, July 6th, Ryan Fukushima sold 10,000 shares of Tempus AI stock. The shares were sold at an average price of $60.00, for a total value of $600,000.00.
• On Tuesday, May 19th, Ryan Fukushima sold 13,550 shares of Tempus AI stock. The stock was sold at an average price of $44.07, for a total value of $597,148.50.

Tempus AI Stock Down 1.9%

Shares of Tempus AI stock opened at $54.61 on Thursday. Tempus AI, Inc. has a 1 year low of $40.77 and a 1 year high of $104.32. The company has a market cap of $9.85 billion, a P/E ratio of -37.92 and a beta of 3.58. The company has a current ratio of 3.30, a quick ratio of 3.16 and a debt-to-equity ratio of 3.06. The stock has a 50-day moving average price of $51.63 and a 200 day moving average price of $51.58.

Tempus AI (NASDAQ:TEM) last issued its earnings results on Thursday, July 30th. The company reported ($0.04) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.10. The company had revenue of $382.49 million for the quarter, compared to the consensus estimate of $379.69 million. Tempus AI had a negative return on equity of 50.28% and a negative net margin of 17.77%.The firm’s quarterly revenue was up 21.6% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.22) EPS. As a group, analysts expect that Tempus AI, Inc. will post -1.38 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on TEM. TD Cowen reissued a “buy” rating on shares of Tempus AI in a research note on Wednesday, July 15th. Guggenheim increased their price objective on Tempus AI from $60.00 to $65.00 and gave the stock a “buy” rating in a report on Thursday, July 16th. Piper Sandler reduced their price objective on Tempus AI from $58.00 to $56.00 and set a “neutral” rating for the company in a research report on Tuesday, August 4th. Stifel Nicolaus lowered their target price on Tempus AI from $60.00 to $50.00 and set a “hold” rating on the stock in a research note on Monday, August 3rd. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Tempus AI in a research report on Wednesday, June 17th. Nine analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $64.92.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of TEM. JPL Wealth Management LLC bought a new stake in Tempus AI in the third quarter worth $26,000. Los Angeles Capital Management LLC bought a new position in Tempus AI during the fourth quarter valued at about $27,000. Harvest Fund Management Co. Ltd bought a new position in Tempus AI during the third quarter valued at about $38,000. Whittier Trust Co. lifted its position in shares of Tempus AI by 190.0% in the first quarter. Whittier Trust Co. now owns 870 shares of the company’s stock worth $41,000 after buying an additional 570 shares during the last quarter. Finally, EverSource Wealth Advisors LLC boosted its stake in shares of Tempus AI by 88.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 691 shares of the company’s stock worth $44,000 after acquiring an additional 325 shares in the last quarter. Institutional investors and hedge funds own 24.22% of the company’s stock.

About Tempus AI

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.